TD Asset Management’s Nektar Therapeutics NKTR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-40,200
| Closed | -$667K | – | 1460 |
|
|
2020
Q3 | $667K | Hold |
40,200
| – | – | ﹤0.01% | 1178 |
|
|
2020
Q2 | $931K | Sell |
40,200
-2,600
| -6% | -$60.2K | ﹤0.01% | 1077 |
|
|
2020
Q1 | $764K | Buy |
42,800
+15,800
| +59% | +$282K | ﹤0.01% | 1065 |
|
|
2019
Q4 | $583K | Sell |
27,000
-54,618
| -67% | -$1.18M | ﹤0.01% | 1211 |
|
|
2019
Q3 | $1.49M | Buy |
81,618
+5,100
| +7% | +$92.9K | ﹤0.01% | 979 |
|
|
2019
Q2 | $2.72M | Sell |
76,518
-7,723
| -9% | -$275K | ﹤0.01% | 845 |
|
|
2019
Q1 | $2.83M | Buy |
84,241
+427
| +0.5% | +$14.3K | ﹤0.01% | 832 |
|
|
2018
Q4 | $2.76M | Sell |
83,814
-5,305
| -6% | -$174K | ﹤0.01% | 833 |
|
|
2018
Q3 | $5.43M | Sell |
89,119
-5,574
| -6% | -$340K | 0.01% | 703 |
|
|
2018
Q2 | $4.62M | Sell |
94,693
-32,927
| -26% | -$1.61M | 0.01% | 734 |
|
|
2018
Q1 | $13.6M | Buy |
127,620
+104,820
| +460% | +$11.1M | 0.02% | 456 |
|
|
2017
Q4 | $1.36M | Buy |
+22,800
| New | +$1.36M | ﹤0.01% | 971 |
|
|
2017
Q2 | – | Sell |
-16,300
| Closed | -$383K | – | 1356 |
|
|
2017
Q1 | $383K | Sell |
16,300
-1,600
| -9% | -$37.6K | ﹤0.01% | 1274 |
|
|
2016
Q4 | $220K | Sell |
17,900
-200
| -1% | -$2.46K | ﹤0.01% | 1331 |
|
|
2016
Q3 | $311K | Buy |
+18,100
| New | +$311K | ﹤0.01% | 1294 |
|
|
2014
Q2 | – | Sell |
-19,000
| Closed | -$230K | – | 1305 |
|
|
2014
Q1 | $230K | Hold |
19,000
| – | – | ﹤0.01% | 1212 |
|
|
2013
Q4 | $216K | Buy |
19,000
+1,900
| +11% | +$21.6K | ﹤0.01% | 1216 |
|
|
2013
Q3 | $179K | Hold |
17,100
| – | – | ﹤0.01% | 1211 |
|
|
2013
Q2 | $198K | Buy |
+17,100
| New | +$198K | ﹤0.01% | 1135 |
|